TTC maintains a monthly e-mail service to notify you of new opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.
Uses of Cyanovirin-N for Anti-Hiv and Anti-Influenza Therapeutics and Prophylactics
T Cell Receptors that Recognize the Tyrosinase Tumor Antigen
Cancer Therapeutic Based on T Cell Receptors Designed to Regiospecifically Release Interleukin-12